Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers (Q33747987)

29 July 2017

title

Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

29 July 2017

0 references

10

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

29 July 2017

6

M Mintun

1 reference

29 July 2017

S M Landau

1

1 reference

29 July 2017

B A Thomas

2

1 reference

29 July 2017

L Thurfjell

3

1 reference

29 July 2017

M Schmidt

4

1 reference

29 July 2017

R Margolin

5

1 reference

29 July 2017

M Pontecorvo

7

1 reference

29 July 2017

S L Baker

8

1 reference

29 July 2017

W J Jagust

9

1 reference

29 July 2017

publication date

20 March 2014

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

29 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

volume

41

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

1398-1407

1 reference

Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Association of lifetime cognitive engagement and low β-amyloid deposition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Relationships between biomarkers in aging and dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

PET imaging of amyloid deposition in patients with mild cognitive impairment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055504

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Characterization of PiB binding to white matter in Alzheimer disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2753-3

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24647577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-014-2753-3

1 reference

29 July 2017

1 reference

29 July 2017

1 reference